MassAITC Webinar: Do AI Scribes Help or Harm Older Adults? Randomized Trial

The Massachusetts AI and Technology Center for Connected Care in Aging & Alzheimer’s Disease (MassAITC) webinar will introduce Accelerating Platforms for Evaluating and eXecuting AI Lifecycles in Alzheimer's Disease and Related Dementias (APEX-ADRD), followed by a presentation from UCLA David Geffen School of Medicine Associate Professor of Medicine John N. Mafi, MD, MPH. 

Dr. Mafi will share findings from a randomized trial of two ambient AI scribes at UCLA Health, highlighting their impact on physician cognitive load, time savings, clinician-reported inaccuracies and care for older adults. Click here for more information.